Cardiovascular Disease Clinical Trial
Official title:
Vivo Heart: Home-Based Virtual Exercise Program for Older Adults With Cardiovascular Disease
Verified date | April 2024 |
Source | Wake Forest University Health Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This pilot study will assess the feasibility and generate preliminary efficacy data of a novel, synchronous, home-based exercise training program for rural older adults with cardiovascular disease (CVD) using Vivo, an online, live, small group fitness program developed for older adults. It uses individually tailored dual-tasked (i.e., cognitive-motor) exercises to improve strength, endurance, balance, and cognition and incorporates social engagement. Certified trainers deliver instruction and coaching through an interactive session (45 min, 2-3 times/week) delivered over 12 weeks. Vivo Heart adapts this unique program to meet the cardiac rehabilitation needs of older adults with CVD. The specific aims are to evaluate the feasibility, acceptability, and uptake of Vivo Heart (Aim 1) and obtain pre- and post-intervention measures of exercise capacity, strength, lower-extremity physical function, cognition, quality of life, stress, fatigability, physical activity, and aging biomarkers (Aim 2).
Status | Enrolling by invitation |
Enrollment | 40 |
Est. completion date | July 1, 2025 |
Est. primary completion date | July 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years to 80 Years |
Eligibility | Inclusion Criteria: - 60 - 80 years - Lives in a rural area based on established urban-rural definitions (e.g., RUCA codes, RUCC, UIC) - A qualifying Cardio Vascular Disease (CVD) event or procedure - Cognitively unimpaired Telephone Interview for Cognitive Status (TICS-m =32) - No major depressive symptoms Patient Health Questionnaire (PHQ-8 <10) - Ambulatory and community-dwelling - Less than 150 min per week of moderate-to-intensive aerobic or resistance exercise in the past month - Medically cleared for exercise if event was within the last 6 months - Access to a tablet or computer and internet/Wi-Fi in defined exercise space - Able to provide own transportation to study visits - Not participating in a clinical trial - Willing to provide informed consent Exclusion Criteria: - <60 years or >80 years - Lives in non-rural area - No CVD or a qualifying event or procedure - Dementia or severe cognitive impairment (TICS-m <32) - Clinical depression (PHQ-8 =10) - Non-ambulatory, institutionalized, or requires walker - Regular aerobic or resistance exercise (including current participation in a cardiac rehab program) - Not medically cleared for exercise - Advanced kidney disease requiring dialysis or dialysis anticipated within 6 months - Insulin-dependent diabetes - Use of any supplemental oxygen for COPD - Significant impairment from a prior stroke - Progressive neurologic disease (Parkinson's, ALS, multiple sclerosis, Alzheimer's disease, dementia) - Severe arthritis, fracture, chronic injury, or other musculoskeletal disorder that prevents walking independently - Cancer (not including non-melanoma skin cancers) requiring treatment with the past year - Excessive alcohol consumption (>7/week alcoholic beverages for women and >14/week for men) in the past month - Joint replacement or other orthopedic surgery in past 12 months or planned in next 6 months - No computer, tablet or internet access - No access to transportation for travel to study visits - Current participation in a clinical trial - Inability or unwillingness to comply with the study requirements |
Country | Name | City | State |
---|---|---|---|
United States | Wake Forest University Health Sciences | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Wake Forest University Health Sciences | National Institute on Aging (NIA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | VO2 peak | Change in VO2 peak | Week 12 | |
Other | Montreal Cognitive Assessment (MoCA) | Change in overall cognition (0-30) | Week 12 | |
Other | Digit Symbol Coding (DSC) | Change in processing speed, working memory, visuospatial processing, and attention (secs) | Week 12 | |
Other | Timed Up and Go (TUG) | Change in time to complete (secs) | Week 12 | |
Other | Expanded Short Physical Performance Battery (eSPPB) | Change in score (0-4) | Week 12 | |
Other | The Four Square Step Test (FSST) | Change in time to complete (secs) | Week 12 | |
Other | 4-step Stair Climb Test (4SCT) | Change in time to complete (secs) | Week 12 | |
Other | Grip Strength | Change in grip strength (kg) | Week 12 | |
Other | Perceived Stress Scale (PSS) | Change in score | Week 12 | |
Other | Short Form-36 Health Survey (SF-36) | Change in score | Week 12 | |
Other | UCLA Loneliness Scale | Change in score | Week 12 | |
Other | Life Space | Change in score | Week 12 | |
Other | Pittsburgh Fatigability Scale (PFS) | Change in score | Week 12 | |
Other | Blood pressure | Change in systolic and diastolic blood pressure (mmHg) | Week 12 | |
Other | Heart rate | Change in resting heart rate (bpm) | Week 12 | |
Primary | Completion Rate | Completion rate which will be determined by the percentage of enrolled participants who complete the study with =80% compliance. | Week 12 | |
Secondary | Recruitment Rate | Recruitment rate will be determined by the total number of enrolled participants divided by the number of months recruitment occurred. | Year 1 | |
Secondary | Recruitment Yield | Recruitment yield will be determined based on the number of participants randomized relative to the total number of volunteers screened | Year 1 | |
Secondary | Compliance Rate | Compliance will be determined based on adherence to the prescribed intervention. Compliance metrics will include attendance at the exercise sessions, health education classes, and dietary counseling sessions. | Week 12 | |
Secondary | Retention Rate | Retention will be determined by the percentage of enrolled participations who complete follow-up testing. | Week 12 | |
Secondary | Satisfaction Survey Scores | Acceptability will be assessed at the end of the study using a program satisfaction survey. | Week 12 | |
Secondary | Continuation Rate | Uptake will be determined by the number of participants who continue in the Vivo program after the study is over. | Year 1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Completed |
NCT02502812 -
Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04216342 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03654313 -
Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
|
Phase 1 | |
Completed |
NCT03646656 -
Heart Health Buddies: Peer Support to Decrease CVD Risk
|
N/A | |
Completed |
NCT02081066 -
Identification of CETP as a Marker of Atherosclerosis
|
N/A | |
Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
Recruiting |
NCT03095261 -
Incentives in Cardiac Rehabilitation
|
N/A | |
Completed |
NCT02589769 -
Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons
|
N/A | |
Completed |
NCT02998918 -
Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL
|
N/A | |
Completed |
NCT02711878 -
Healing Hearts and Mending Minds in Older Adults Living With HIV
|
N/A | |
Not yet recruiting |
NCT02578355 -
National Plaque Registry and Database
|
N/A | |
Completed |
NCT02868710 -
Individual Variability to Aerobic Exercise Training
|
N/A | |
Recruiting |
NCT02885792 -
Coronary Artery Disease in Patients Suffering From Schizophrenia
|
N/A | |
Completed |
NCT02640859 -
Investigation of Metabolic Risk in Korean Adults
|
||
Completed |
NCT02272946 -
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
|
Phase 2 | |
Completed |
NCT02657382 -
Mental Stress Ischemia: Biofeedback Study
|
N/A | |
Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
Recruiting |
NCT02265250 -
Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
|